TY  - CHAP
M1  - Book, Section
TI  - Chapter 5. Ethical, Legal, and Social Issues Associated with Pharmacogenomics
A1  - Ma, Joseph D.
A1  - Lewis, Karen E.
A1  - Bertino, Joseph S.
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
PY  - 2013
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - To  identify  the  current  ethical,  legal,  and  social  issues  associated  with  pharmacogenomics  and  pharmacogenomic  testing.To  understand  how  genetic  discrimination,  stigmatization,  and  privacy  and  confidentiality  impact  the  implementation  of  pharmacogenomic  testing  into  clinical  practice.To  understand  the  legal  issues  involving  pharmacogenomic  testing  regarding  the  ownership  of  data  and/or  samples  and  intellectual  property.To  develop  a  knowledge  base  involving  pharmacogenomic  core  competencies.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/16
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56875566
ER  -